Naftidrofuryl (Oxalate)
Also known as: Nafroyl, Nofrayl oxalate
Naftidrofuryl (Oxalate) is used as a vasodilator in the treatment of peripheral and cerebral vascular disorders. Naftidrofuryl (Oxalate) is also claimed to enhance cellular oxidative capacity thereby protecting cells against the results of ischaemia.
Primary Characteristics
Naftidrofuryl (Oxalate) is also known as Nafroyl, Nofrayl oxalate.
It is of Synthetic origin and belongs to Furfuryl Propionate.
It belongs to Vasodilators pharmacological group on the basis of mechanism of action and also classified in Antihypertensive Agents pharmacological group.
Molecular Weight: 473.6 · pKa: 8.7 · Solubility in Water: readily soluble · Solubility in Alcohol: Freely soluble · Non-proprietary name: Naftidrofuryl (Oxalate).

Pharmacokinetics
Absorption: Naftidrofuryl (Oxalate) has an oral bioavailability is 92.5% (±6.5%), pre-systemic (first-pass) metabolism accounts for 45.5% (±4.5%).
Distribution: Naftidrofuryl (Oxalate) has a volume of distribution is 124.69+-41.12ml/min. plasma protein binding is <80%.
Elimination: it is metabolised via Hepatic, plasma half-life is 1 hr, renal excretion is 80 %.
Advertisement
Indications
Naftidrofuryl (Oxalate) is primarily indicated in conditions like Peripheral vascular disease, Raynaud's phenomenon, Sedative in combined anaesthesia.
Naftidrofuryl (Oxalate) is also indicated for secondary conditions like Alzheimer's disease, Dementia.
Contraindications
None recorded.
Dosage
Naftidrofuryl (Oxalate)'s dosage details are as follows:
| Dose | Single Dose | Frequency | Route | Instructions |
|---|---|---|---|---|
| Adult Dosage | ||||
| 150 mg | 150 mg | Every 8h | PO | For at least 3 months |
| Paediatric Dosage (20kg) | ||||
| No data. | ||||
| Neonatal Dosage (3kg) | ||||
| 0 – 0 | — | — | Not indicated in this age group | |
Drug Interactions
None recorded.
Side Effects
Naftidrofuryl (Oxalate) in overdosage may give rise to further complications which include Hepatitis , Hepatic failure.
The signs and symptoms that are produced after acute overdosage of Naftidrofuryl (Oxalate) are Hypotension, Convulsions , Unconsciousness, Depression of Cardiac conduction.
Naftidrofuryl (Oxalate) is known to cause more or less tolerable side effects which are usually transient. These include Epigastric pain, Nausea, Rashes .
Warnings / Precautions
Available Brands
None recorded.
Storage Conditions
Drug Classification
- 1.12.3.7 — Direct vasodilators